期刊文献+

下调ALDH1A1基因表达对体外培养的鼻咽癌细胞系迁移能力的影响

Influence of down-regulating the expression of ALDH1A1 on the migration and invasion of nasopharyngeal carcinoma cell lines in vitro
原文传递
导出
摘要 目的探讨siRNA干扰ALDH1A1基因表达对鼻咽癌5-8F和CNE2细胞迁移侵袭能力的影响。方法将鼻咽癌5-8F和CNE2细胞分为5-8F干扰组、5-8F空载组、CNE2干扰组、CNE2空载组,利用已构建的慢病毒pMagic 4.1-ALDH1A1siRNA载体和pMagic 4.1-shRNA空载体分别感染5-8F和CNE2细胞,建立稳定干扰ALDH1A1表达的鼻咽癌5-8F、CNE2细胞株和空载的5-8F和CNE2细胞株。4组采用Western blot法检测细胞ALDH1A1、血管内皮生长因子(vascular endothelial growth factor,VEGF)、基质金属蛋白酶(matrix metalloproteinase,MMP)-2、MMP-9蛋白表达,采用Transwell小室实验检测各组迁移细胞数,采用Boyden小室实验检测各组侵袭细胞数。结果 5-8F干扰组ALDH1A1蛋白表达(0.34±0.01)低于5-8F空载组(0.75±0.03),CNE2干扰组ALDH1A1蛋白表达(0.24±0.03)低于CNE2空载组(0.71±0.03);5-8F干扰组鼻咽癌细胞迁移细胞数(35.0±2.6)、侵袭细胞数(32.7±2.1)均低于5-8F空载组(117.6±3.2,105.6±4.0),CNE2干扰组鼻咽癌细胞迁移细胞数(34.0±3.0)、侵袭细胞数(32.3±1.5)均低于CNE2空载组(121.0±4.0,108.0±1.7)(P<0.01);5-8F干扰组VEGF(0.49±0.03)、MMP-2(0.36±0.04)、MMP-9(0.31±0.04)蛋白表达低于5-8F空载组(0.73±0.02、0.50±0.02、0.89±0.01)(P<0.01),CNE2干扰组VEGF(0.48±0.02)、MMP-2(0.37±0.02)、MMP-9(0.41±0.02)蛋白表达低于CNE2空载组(0.78±0.05、0.67±0.05、0.76±0.04)(P<0.01)。结论下调ALDH1A1基因表达可抑制鼻咽癌细胞迁移侵袭。 Objective To investigate the effect of ALDH1A1 silence on the migration and invasion of nasopharyngeal carcinoma cell lines 5-8F and CNE2. Methods The nasopharyngeal carcinoma 5-8F and CNE2 cell lines were divided into 5-8F shRNA-ALDH1A1 group, 5-8F control group, CNE2 shRNA-ALDHIA1 group, and CNE2 control group. The lentiviral pMagic 4. 1-ALDHIA1 siRNA and pMagic 4. 1-shRNA were used to transfect 5-8F and CNE2 cell lines respectively to construct 5-8F, CNE2, 5-8F vector and CNE2 vector cell lines stably interfering the expression of ALDH1A1. The protein expression of ALDH1A1, vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP)-2 and MMP-9 were evaluated with Western blot in four groups. The counts of migration and invasion cells were detected by Transwell chamber and Boyden chamber assay. Results The expression of ALDH1A1 was significantly lower in 5-8F shRNA-ALDH1A1 group (0. 34±0. 01) than that in 5-8F vector group (0. 75 ± 0. 03), and in CNE2 shRNA-ALDH1A1 group (0.24±0.03) than that in CNE2 vector group (0.71±0.03) (P〈0.05). The migration and invasion cell counts were significantly lower in 5-8F shRNA-ALDHIA1 group (5.0 ± 2.6, 32.7 ± 2.1) than those in 5-8F vector group (117.6±3.2, 105.6d=4.0), and in CNE2 shRNA-ALDH1A1 group (34.0±3.0, 32.3±1.5) than those in CNE2 vector group (121. 0±4. 0, 108. 0±1. 7) (P〈0.01). The expressions of VEGF, MMP-2 and MMP-9 were significantly lower in 5-8F shRNA-ALDH1A1 group (0.49±0.03, 0. 36±0. 04, 0. 31±0. 04) than those in 5-8F vector group (0.73±0.02, 0.50±0.02, 0.89±0.01) (P〈0.01), in CNE2 shRNA-ALDH1A1 group (0.49±0.03, 0.36±0.04, 0. 31±0. 04) than those in CNE2 vector group (0.78±0.05, 0. 67±0. 05, 0. 76±0. 04) (P〈0.01). Conclusion The down-regulation of ALDH1A1 could inhibit the migration and invasion of nasopharyngeal carcinoma cells.
作者 吴爱兵 李金媚 罗怡平 麦宗炯 杨志雄 WU Ai-bing;LI Jin-mei;LUO Yi-ping;MAI Zong-jiong;YANG Zhi-xiong(Department of Oncology , the Affiliated Hospital of Guangdong Medical University, Zhanjiang 524000, Chin)
出处 《中华实用诊断与治疗杂志》 2018年第4期327-330,共4页 Journal of Chinese Practical Diagnosis and Therapy
基金 国家自然科学基金青年基金(81201672) 广东省科技计划项目(2016A020215228) 广东医学院博士启动基金(B2012032)
关键词 鼻咽癌 乙醛脱氢酶A1 侵袭迁移 Nasopharyngeal carcinoma, ALDHIAI migration and invasion
  • 相关文献

参考文献5

二级参考文献57

  • 1马春树,方伟岗,崔湘琳,刘宇欣,由江峰,吴秉铨,郑杰,王洁良.Identification of tumor metastasis-related gene TMSG-1 by mRNA differential display[J].Science China(Life Sciences),2002,45(5):553-560. 被引量:13
  • 2姜亚磊,闫晓英,狄烊,孟天娇,金宏,齐玲.血管内皮生长因子与几种肿瘤发生发展的关系[J].吉林医药学院学报,2013,34(4):286-288. 被引量:7
  • 3肖大江,吴四海,朱国臣,袁渊,张永胜,吕春江,赵新.声门上型喉癌中乙酰肝素酶的表达及意义[J].山东医药,2007,47(6):24-25. 被引量:2
  • 4IKEGUCHI M, FUKUDA K, YAMAGUCHI K, et al. Quantitative analysis of heparanase gene expression in esophageal squamous cell careinoma[J]. Ann Surg Oncol, 2003,10 : 297 - 304.
  • 5KELLY T, SUVA L J, HUANG Y, et al. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastasis[J]. Cancer Res, 2005, 65:5778-5784.
  • 6VLODAVSKY I, ABBOUD-JARROUS G, ELKIN M, et al. The impact of heparanase and heparin on cancer metastasis and angiogenesis[J]. Pathophysiol Haemost Thromb, 2006,35:116-127.
  • 7REILAND J, SANDERSON R D, WAGUESPACK M, et al. Heparanase degrades syndecan 1 and perlecan heparan sulfate: functional implications for tumor cell invasion[J]. J Biol Chem, 2004, 279: 8047 - 8055.
  • 8BAR-SELA G, KAPLAN-COHEN V,ILAN N,et al. Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival[J]. Histopathology, 2006,49:188-193.
  • 9BASCHE M, GUSTAFSON D L, HOLDEN S N, et al. A phase Ⅰ biological and pharmacologic study of the heparanase inhibitor PL88 in patients with advanced solid tumors[J]. Clin Cancer Res, 2006,12:5471-5480.
  • 10Yoshizaki T,Sato H,Furukawa M,et al. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1[J]. Proc Natl Sci USA,1998,95 (7) :3621-3626.

共引文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部